Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125842771 | 12584277 | 1 | I | 2004 | 20160719 | 20160722 | 20160722 | EXP | US-ASTRAZENECA-2016SE78798 | ASTRAZENECA | 62.00 | YR | M | Y | 123.80000 | KG | 20160722 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125842771 | 12584277 | 1 | PS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 MCG, 2 PUFFS TWICE DAILY | 21929 | BID | |||||||||
| 125842771 | 12584277 | 2 | SS | ATACAND | CANDESARTAN CILEXETIL | 1 | Oral | 0 | 16 | MG | TABLET | QD | |||||||
| 125842771 | 12584277 | 3 | SS | ATACAND | CANDESARTAN CILEXETIL | 1 | Oral | 0 | 16 | MG | TABLET | QD | |||||||
| 125842771 | 12584277 | 4 | SS | ATACAND | CANDESARTAN CILEXETIL | 1 | Oral | 0 | 16 | MG | TABLET | QD | |||||||
| 125842771 | 12584277 | 5 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 0 | 10 | MG | TABLET | QD | |||||||
| 125842771 | 12584277 | 6 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | 0 | 1.25 | UG | QD | ||||||||
| 125842771 | 12584277 | 7 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 0 | 150 | UG | QD | ||||||||
| 125842771 | 12584277 | 8 | C | WARFARIN | WARFARIN | 1 | Oral | 0 | 5 | MG | |||||||||
| 125842771 | 12584277 | 9 | C | WARFARIN | WARFARIN | 1 | Oral | 0 | 2.5 | MG | BIW | ||||||||
| 125842771 | 12584277 | 10 | C | LASIX | FUROSEMIDE | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
| 125842771 | 12584277 | 11 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Intravenous (not otherwise specified) | 0 | 40 | MG | QD | ||||||||
| 125842771 | 12584277 | 12 | C | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Oral | 0 | 25 | MG | QD | ||||||||
| 125842771 | 12584277 | 13 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | Oral | 0 | 5 | MG | QD | ||||||||
| 125842771 | 12584277 | 14 | C | MOMETASONE FUROATE. | MOMETASONE FUROATE | 1 | Nasal | 0 | 2 | DF | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125842771 | 12584277 | 1 | Chronic obstructive pulmonary disease |
| 125842771 | 12584277 | 2 | Hypertension |
| 125842771 | 12584277 | 3 | Hypertension |
| 125842771 | 12584277 | 4 | Hypertension |
| 125842771 | 12584277 | 5 | Blood cholesterol abnormal |
| 125842771 | 12584277 | 6 | Chronic obstructive pulmonary disease |
| 125842771 | 12584277 | 7 | Thyroid disorder |
| 125842771 | 12584277 | 8 | Arrhythmia |
| 125842771 | 12584277 | 9 | Arrhythmia |
| 125842771 | 12584277 | 10 | Fluid retention |
| 125842771 | 12584277 | 11 | Fluid retention |
| 125842771 | 12584277 | 12 | Cardiac disorder |
| 125842771 | 12584277 | 13 | Cardiac disorder |
| 125842771 | 12584277 | 14 | Nasal congestion |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125842771 | 12584277 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125842771 | 12584277 | Arrhythmia | |
| 125842771 | 12584277 | Cardiac failure | |
| 125842771 | 12584277 | Chronic obstructive pulmonary disease | |
| 125842771 | 12584277 | Cough | |
| 125842771 | 12584277 | Fluid retention | |
| 125842771 | 12584277 | Glucose tolerance impaired | |
| 125842771 | 12584277 | Sleep apnoea syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125842771 | 12584277 | 8 | 201605 | 0 | ||
| 125842771 | 12584277 | 9 | 201605 | 0 | ||
| 125842771 | 12584277 | 10 | 201606 | 201606 | 0 | |
| 125842771 | 12584277 | 11 | 201606 | 0 | ||
| 125842771 | 12584277 | 12 | 201605 | 0 | ||
| 125842771 | 12584277 | 13 | 201605 | 0 | ||
| 125842771 | 12584277 | 14 | 2015 | 0 |